Medical Digest & Congress Report
Episodes
PSMAfore Study Unveils Game-Changing Results for Prostate Cancer Treatment - report from ESMO2023
30 Oct 2023
Contributed by Lukas
Professor Oliver Sartor highlights findings from the phase 3 PSMAfore trial exploring 177Lu-PSMA-617 in patients with taxane-naive metastatic castrati...
Considerations of moderate asthma management - report from ERS2023
04 Oct 2023
Contributed by Lukas
Professor Giorgio Walter Canonica sharing his insights on moderate asthma treatment. The professor will give answers to questions such as: - According...
Heart Failure management in the post-COVID era - Lessons from the pandemic - report from ESC2023
13 Sep 2023
Contributed by Lukas
Professor Theresa McDonagh discusses how to deal with the legacy of COVID-19 for our patients and shares her advices. Video: https://medicaldigest.org...
Key points from the 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - report from ESC2023
13 Sep 2023
Contributed by Lukas
Professor Marco Metra was the co-chairman of the update to the ESC Heart Failure guidelines of 2021. The update incorporate data from nearly a dozen n...
Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19 - report from ESC2023
12 Sep 2023
Contributed by Lukas
Professor Mikhail Kosiborod explains the findings of the Meta-Analysis, shows SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19...
Burden of Cardiovascular Disease in the European Union - report from ESC2023
12 Sep 2023
Contributed by Lukas
Professor Panos Vardas highlights the economic burden of cardiovascular diseases in the European Union. CVD cost the EU an estimated €282 billion in...
Highlights of ESC2023 Congress - Heart failure in focus - report from ESC2023
12 Sep 2023
Contributed by Lukas
Professor Carlos Aguiar discusses the highlights of the ESC2023 annual congress, shares his thougths on many great news, novelties that could be chang...
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes - from the cardiologist's perspective - report from ESC2023
11 Sep 2023
Contributed by Lukas
Professor Nikolaus Marx, was the co-chairman of the new European Society of Cardiology Guidelines of the Management of Cardiovascular Disease in Patie...
Main headlines of 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - report from ESC2023
11 Sep 2023
Contributed by Lukas
Professor Theresa McDonagh was the co-chair of the update to the ESC Heart Failure guidelines of 2021 which incorporates data from nearly a dozen new ...
STEP HFpEF: once-weekly semaglutide in people with HFpEF and obesity - report from ESC2023
11 Sep 2023
Contributed by Lukas
Professor Mikhail Kosiborod provides a summary of the STEP HFpEF trial, in which semaglutide improves heart failure-related symptoms and physical func...
When real-world data meet real patients' needs: how to optimally treat patients with chronic coronary syndromes in 2023? - report from ESC2023
11 Sep 2023
Contributed by Lukas
Professor Luis Henrique Gowdak share his thought how to treat patients optimally with chronic coronary syndromes in 2023. Video: https://medicaldigest...
OCT vs. IVUS vs. angiography guidance: a real-time updated network meta-analysis - report from ESC2023
07 Sep 2023
Contributed by Lukas
Professor Gregg Stone provides a summary from a real-time updated network meta-analysis comparing OCT, IVUS and Angiography guidance in percutaneous c...
2023 ESC Guidelines for the Management of Endocarditis - report from ESC2023
07 Sep 2023
Contributed by Lukas
Professor Michael A. Borger, was the co-chairman of the new European Society of Cardiology Guidelines for the Management of Endocarditis. The overarch...
DICTATE-AHF: Early Dapagliflozin Initiation in Acute Heart Failure - report from ESC2023
07 Sep 2023
Contributed by Lukas
Professor Zachary Cox provides a summary of the DICTATE-AHF trial which showed that in patients with ADHF requiring inpatient IV loop diuretic therapy...
HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency - report from ESC2023
07 Sep 2023
Contributed by Lukas
Professor Robert Mentz provides a summary of the HEART-FID trial. The study investigated the long-term safety and efficacy of supplementing heart fail...
BUDAPEST CRT Upgrade: Cardiac resynchronisation therapy upgrade in heart failure with right ventricular pacing - a multicentre, randomised, controlled trial - report from ESC2023
06 Sep 2023
Contributed by Lukas
Professor Bela Merkely provides a summary of the BUDAPEST CRT Upgrade trial. The randomized, multicenre study shows, that among patients with heart fa...
2023 ESC Guidelines for the Management of Acute Coronary Syndromes - report from ESC2023
06 Sep 2023
Contributed by Lukas
Professor Borja Ibanez co-chaired of the new 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes. This is th...
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes - from the diabetologist's perspective - report from ESC2023
06 Sep 2023
Contributed by Lukas
Professor Massimo Federici, was the co-chairman of the new European Society of Cardiology Guidelines of the Management of Cardiovascular Disease in ...
2023 ESC Guidelines for the Management of Cardiomyopathies - report from ESC2023
06 Sep 2023
Contributed by Lukas
Professor Juan Pablo Kaski co-chaired the brand new European Society of Cardiology Guidelines for the Management of Cardiomyopathies. This is the fi...
What is the optimal treatment of hypertension in diabetics? The ESH 2023 Hypertension Guidelines on Diabetes - report from ESH2023
18 Jul 2023
Contributed by Lukas
Professor Josep Redon shares his insights on the special issues the European Society of Hypertension Guidelines covers, focusing on the best treatment...
Diabetes trials on SGLT2 and GLP1 and their effects on hypertension - report from ESH2023
18 Jul 2023
Contributed by Lukas
Professor Peter Nilsson held a lecture on the cardiovascular effects of SGLT-2 inhibitors and GLP-1 agonists, the two new drug classes which revolutio...
The Rehabilitation of Beta-Blockers in the ESH Hypertension Guidelines - report from ESH2023
12 Jul 2023
Contributed by Lukas
Professor Sverre Erik Kjeldsen explains how the role of the beta-blockers changed a in the new ESH Hypertension guideline. Video: https://medicaldiges...
Hypertensive patients with diabetes: Are RAAS/Diuretic combinations the foundation of treatment? - report from ESH2023
12 Jul 2023
Contributed by Lukas
Professor Otavio Berwanger shares his insight related to the management of patients with hypertension and diabetes. Video: https://medicaldigest.org/s...
Managing Hypertension in Real Practice: the New ESH2023 Hypertension Guidelines - report from ESH2023
12 Jul 2023
Contributed by Lukas
Professor Gianfranco Parati shares his insight on the new ESH Hypertension guidelines, how we should better manage hypertension in our patients. Video...
Hyperuricemia in hypertensive patients - report from ESH2023
12 Jul 2023
Contributed by Lukas
Professor Claudio Borghi on the elevated uric acid levels in hypertension. Which patient should be treated, when and how? Video: https://medicaldigest...
Hypertension in women - an underrecognized issue- report from ESH2023
10 Jul 2023
Contributed by Lukas
Professor Renata Cifkova was responsible in the new ESH Hypertension guideline for the topic of hypertension in women. In the interview, she explained...
What has changed in the new ESH Hypertension Guidelines? - report from ESH2023
10 Jul 2023
Contributed by Lukas
Professor Bryan Williams was the driving force behind the 2018 ESH/ESC Hypertension guideline. Many points - including the algorithm for drug therapy ...
When hypertension and dyslipidemia co-exist: How to decrease CV risk? - report from ESH2023
10 Jul 2023
Contributed by Lukas
Dr. Vitoria Cunha explains what is the relationship and effect of hypertension and dyslipidemia on each other? Is it recommended to treat the two risk...
Hypertensive patients with heart disease: What should be the preferred combination? - report from ESH2023
10 Jul 2023
Contributed by Lukas
Professor Konstantinos Tsioufis highlights an important aspect of the new ESH Hypertension guideline: hypertension and cardiac diseases. How these are...
Where is the role of triple combination in the management of hypertension? - report from ESH2023
07 Jul 2023
Contributed by Lukas
Professor Reinhold Kreutz shares his insights about the antihypertensive triple fixed combinations.What pathophysiological bases justify the use of tr...
The development of hypertension guidelines - report from ESH2023
07 Jul 2023
Contributed by Lukas
Professor Neil Poulter share his insights on the development of guidelines and the treatment in general in the last 15 years, and the practical applic...
”Ten Commandments” of Single Pill Combination Treatment in Hypertension - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Krzysztof Narkiewicz Explains his Take on Single Pill Combination Treatment in Hypertension. Video: https://medicaldigest.org/scientific-con...
Beta-blockers in managing arterial hypertension - why, when and to whom? - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Felix Mahfoud explains the place of beta-blockers in the new ESH guideline, and in combination he recommends them even in the first line. Vi...
Beyond the algorithm: What combination to choose in hypertension treatment? - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Martin Strauss explains the preferred treatment of hypertension with a preferred RAAS blockade inhibitors. What kind of pill combination to ...
Antihypertensive Drugs and Treatment Algorithms in the ESH2023 Hypertension Guidelines - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Michel Burnier presented the general aspects of the new European Society of Hypertension guidelines at ESH 2023. What are the major changes?...
Hypertension and kidney - the intricate relationship - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Pantelis Sarafidis shared his insights on kidney disease and hypertension, and what the new ESH guidelines said about the management the hyp...
Hot questions on blood pressure measurement in clinical practice - report from ESH2023
05 Jul 2023
Contributed by Lukas
Professor Paolo Palatini chaired a very interesting session at the ESH 2023 about the hot questions on blood pressure measurement. - How to best perf...
Significant LDL Cholesterol Reductions With ANGPTL3 siRNA in homozygous familial hypercholesterolaemia - report from EAS2023
19 Jun 2023
Contributed by Lukas
Professor Frederick Raal about an interim analysis of a phase 2 study demonstrates that the RNAi therapeutic ARO-ANG3 reduces LDL-c and ApoB in patien...
HER2 treatment landscape 2023 - report from ESMO BC 2023
05 Jun 2023
Contributed by Lukas
Professor Javier Cortés, Head of the International Breast Cancer Center in Barcelona, Spain explains the HER2 treatment landscape in 2023. The interv...
Do overweight and obesity confer an additional risk of CAD in patients with FH? - report from EAS2023
02 Jun 2023
Contributed by Lukas
Professor Amany Elshorbagy explains, that obese children and adults with heterozygous familial hypercholesterolemia have a higher risk of coronary art...
Objective assessement of skin disease severity with the help of AI
26 May 2023
Contributed by Lukas
Dr. Maksym Breslavets, Medical Director of Centre for Medical and Surgical Dermatology in Canada explains how artificial intelligence application may ...
What's new in treatment of breast cancer? - Highlights of ESMO BC 2023
24 May 2023
Contributed by Lukas
Prof. Matteo Lambertini explains the highlights of the 2023 ESMO Breast Cancer Conference. - There are more insights of the toxicity of the new ACD&#...
Hot topics in melanoma management - report from EADO2023
15 May 2023
Contributed by Lukas
We asked Professor Paolo Ascierto, world known expert in the field of skin cancer treatment about hot topics in melanoma management. Based on the curr...
Functional Precision Medicine in Oncology - report from AACR2023
04 May 2023
Contributed by Lukas
Professor Anthony Letai, President of the Society for Functional Precision Medicine explains the concept of functional precision medicine in oncology:...
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator - report from AACR2023
28 Apr 2023
Contributed by Lukas
Jeffrey Weber explains the efficacy and safety results from the randomized, open-label Phase 2 mRNA-4157-P201/Keynote-942 trial presented at ACCR 2023...
Current issues in the treatment of schizophrenia - report from EPA2023
12 Apr 2023
Contributed by Lukas
Professor Istvan Bitter from Semmelweis University, Budapest, Hungary is sharing his insights on schizophrenia treatment. In the last decades numerous...
Highlights of EPA 2023 - report from EPA2023
06 Apr 2023
Contributed by Lukas
Professor Peter Falkai, past president of the European Psychiatric Association, is sharing his insights on the EPA 2023 Congress, guided by the motto ...
The Risk of Early Recurrent MI: What is the Role of Cholesterol Efflux and ApoA-I? - report from ACC2023
04 Apr 2023
Contributed by Lukas
Prosessor Eliot A. Brinton on the risk and incidence of recurrent CV events post-AMI, and the role of cholesterol efflux and ApoA-I in plaque stabiliz...
Bempedoic Acid Improves Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk - report from ACC2023
31 Mar 2023
Contributed by Lukas
Prosessor Eliot A. Brinton explains the results of the CLEAR Outcomes trial, the first study to assess whether bempedoic acid could reduce cardiovascu...
How to increase prescription of evidence-based therapies in adults with T2D and ASCVD? - The COORDINATE-Diabetes Study - report from ACC2023
29 Mar 2023
Contributed by Lukas
Dr. Neha Pagidipati presented the COORDINATE-Diabetes Study's primary results. Evidence-based therapies are under-used in clinical practice, and t...
The FREEDOM COVID Anticoagulation Strategy Randomized Trial - report from ACC2023
28 Mar 2023
Contributed by Lukas
Professor Gregg Stone explains the results of the FREEDOM COVID Anticoagulation Strategy Randomized Trial. The main conclusions are among non-critical...
Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery - UK Mini Mitral Trial - report from ACC2023
27 Mar 2023
Contributed by Lukas
Professor Enoch Akowuah explains the results of the UK Mini Mitral Trial. The best surgical approach for mitral valve repair is widely debated. The tr...
Can Patients with Hypertrophic Cardiomyopathy do Vigorous Exercise? - A Multinational Lifestyle And Exercise Study - report from ACC2023
22 Mar 2023
Contributed by Lukas
Professor Rachel Lampert explains the findings of LIVE-HCM trial presented at ACC.23/WCC: patients with hypertrophic cardiomyopathy who exercised vigo...
Efficacy and Safety of Oral PCSK9 Inhibitor, MK-0616 in the Treatment of Hypercholesterolemia - report from ACC2023
21 Mar 2023
Contributed by Lukas
Professor Eliot Brinton, the President, Utah Lipid Center, Salt Lake City explains the results of the research led by Professor Christie Ballantyne, t...
Transcatheter Edge-to-Edge Repair of Functional Mitral Regurgitation in Heart Failure - The COAPT Trial - report from ACC2023
20 Mar 2023
Contributed by Lukas
Professor Gregg Stone explains details on the COAPT trial which set out to assess the safety and efficacy of transcatheter mitral leaflet approximatio...
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease - report from ACC2023
16 Mar 2023
Contributed by Lukas
Searching for potential cardiovascular risk factors led to many discoveries in the last decades and radically changed our view on CV prevention. Profe...
Sotatercept in combination with background therapy for the treatment of Pulmonary Arterial Hypertension — STELLAR Trial - report from ACC2023
14 Mar 2023
Contributed by Lukas
Professor Marius Hoeper explains the results of a phase 3 trial of sotatercept for treatment of Pulmonary Arterial Hypertension. The conclusion is tha...
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA - report from ACC2023
10 Mar 2023
Contributed by Lukas
Professor Eliot A. Brinton talks about a new development about the use of Omega-3 fatty acids at the American College of Cardiology and World Congress...
LMWH use in pregnancy: The Highlow and the ALPINE trial - report from ASH2022
10 Jan 2023
Contributed by Lukas
Professor Saskia Middeldorp talks about two very important trails were published on LMWH use in pregnancy in 2022. The first one is the Highlow study ...
Treatment options for early, HR+, HER2- Breast Cancer - report from SABCS2022
10 Jan 2023
Contributed by Lukas
Professor Hope Rugo were speaker and co-author of several presentations at this years San Antonio Breast Cancer Symposium. We asked her about early st...
Post neoadjuvant therapy in Triple Negative Breast Cancer - report from SABCS2022
10 Jan 2023
Contributed by Lukas
Professor Hope Rugo were speaker and co-author of several presentations at this years San Antonio Breast Cancer Symposium. We asked her about triple n...
Highlights of the San Antonio Breast Cancer Symposium 2022 - report from SABCS2022
15 Dec 2022
Contributed by Lukas
Professor Virginia Kaklamani speak about the novelties and state of the art treatment presented at SABCS 2022. (DESTINY-Breast02 trial Trastuzumab Der...
Targeting CV risk factors with GLP-1 RAs in people with obesity - report from EASD2022
18 Oct 2022
Contributed by Lukas
Professor Michael Lincoff shares with us a discussion occurred during the EASD 2022 meeting, this was focusing on the modification of cardiovascular r...
Once weekly insulin: The ONWARDS 2 study - report from EASD2022
13 Oct 2022
Contributed by Lukas
Professor Tina Vilsbøll chaired a very interesting session looking into once weekly insulin. Video: https://congressreport.eu/scientific-contents/int...
Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction - report from EASD2022
12 Oct 2022
Contributed by Lukas
We asked Professor Silvio Inzucchi about the key messages of the DELIVER study, he talked about this topic at the recent EASD 2022. Video: https://con...
Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg - report from EASD2022
11 Oct 2022
Contributed by Lukas
Domenica Rubino, Director of Washington Center for Weight Management & Research at Arlington, Virginia, USA, held a very interesting lecture about...
Semaglutide 2.4 mg reduces the 10-year type 2 diabetes risk in people with overweight or obesity - report from EASD2022
11 Oct 2022
Contributed by Lukas
Professor Timothy Garvey, Director of Diabetes Research Center at University of Alabama presented new data from the STEP trial program at this year EA...
Let’s talk about CGM evidence: Using basal insulins in T1D in daily life and when exercising - report from EASD2022
05 Oct 2022
Contributed by Lukas
Continuous glucose monitoring gives us the opportunity to better analyze diabetes. The new insights help us to improve the therapy of our patients in ...
Primary results of the phase 3 KEYNOTE-412 study - report from ESMO2022
05 Oct 2022
Contributed by Lukas
Professor Jean-Pascal Machiels Head of the Department of Medical Oncology at the Cliniques Universitaires Sain-Luc, Brussels, presented results of the...
Treatment with tumor-infiltrating lymphocytes versus ipilimumab for advanced melanoma - report from ESMO2022
29 Sep 2022
Contributed by Lukas
Professor John Haanen from the Netherlands Cancer Institute presented the first randomized phase 3 trial on treatment with tumor-infiltrating lymphocy...
Effect of liraglutide on muscle fat infiltration in adults with overweight or obesity - report from EASD2022
28 Sep 2022
Contributed by Lukas
Professor Ambarish Pandey presented the results a randomised clinical trial about the effect of liraglutide on muscle fat infiltration in overweight o...
The IPSOS trial - report from ESMO2022
23 Sep 2022
Contributed by Lukas
Siow Ming Lee, Professor of Medical Oncology at University College London, presented the results of the IPSOS trial at the ESMO 2022 Congress. This wa...
Choices in asthma and COPD care: How to maximize outcomes for patients - report from ERS2022
19 Sep 2022
Contributed by Lukas
Professor Charlotte Suppli Ulrik took part in a very interesting session at this years ERS congress on how to maximize patients outcome in asthma and ...
A fresh look at pulmonary hypertension: practical takeaways for patient management - report from ESC2022
13 Sep 2022
Contributed by Lukas
Dr John Coghlan going to share his insights with us on evidence - based treatment decisions in pulmonary arterial hypertension. Video: https://co...
Influenza Vaccine Among Patients with Acute Coronary Syndromes: the VIP-ACS trial - report from ESC2022
12 Sep 2022
Contributed by Lukas
Professor Remo Furtado had an important presentation on the Influenza Vaccine among patients with Acute Coronary Syndromes at this year’s ESC Congre...
Facing anticoagulation dilemmas in venous thromboembolism - report from ESC2022
12 Sep 2022
Contributed by Lukas
Professor Ingrid Pabinger held a presentation on extended anticoagulation in venous thromboembolism at the recent ESC Congress in Barcelona. We asked ...
The importance of optimal RAASi therapy in heart failure - report from ESC2022
08 Sep 2022
Contributed by Lukas
Professor Dan Atar had an important presentation on the importance of optimal RAASi therapy in heart failure at this year’s ESC Congress. He is goin...
Chronic coronary syndrome: re-thinking treatment management and outcome priorities - report from ESC2022
07 Sep 2022
Contributed by Lukas
Professor Athanasios J. Manolis chaired a very eye-opening session on how to improve care in patients with chronic coronry syndrome at this years ESC ...
Dual antiplatelet therapy in practice - report from ESC2022
06 Sep 2022
Contributed by Lukas
Professor Roxana Mehran chaired a very special Guidelines in Practice session at this year’s ESC Congress on dual antiplatelet therapy. We asked her...
2022 ESC-ERS Guidelines for the diagnosis and treatment of pulmonary hypertension - report from ESC2022
05 Sep 2022
Contributed by Lukas
Professor Marion Delcroix co-chareid the session presenting the 2022 ESC-ERS guideline for the diagnosis and treatment of pulmonary hypertension at th...
Guidelines in Practice: management of dyslipidaemias in the elderly - report from ESC2022
05 Sep 2022
Contributed by Lukas
Professor Ricardo Asteggiano chaired a guideline is practice session on the management of dyslipidaemias in the elderly at this years ESC Congress. We...
Guidelines in Practice: dual antiplatelet therapy (DAPT) - report from ESC2022
02 Sep 2022
Contributed by Lukas
Professor Robert Storey co-chaired a very interesting Guidelines in Practice session on dual antiplatelet therapy at this year’s ESC Congress.  ...
Getting to LDL-C goals and staying there long-term - report from ESC2022
01 Sep 2022
Contributed by Lukas
Professor Mamas Mamas chaired a very interesting interactive session at this years ESC Congress in Barcelona. We asked him to share his insights with ...
Cardiorenal benefits of finerenone: protecting the heart and kidneys - report from ESC2022
01 Sep 2022
Contributed by Lukas
Professor George Bakris chaired a very interesting session at the recent ESC Congress on the Cardiorenal benefits of finerenone, which is indicated fo...
The Journey to Address Unmet Needs Across all Haemophilia Indications - report from ISTH2022
29 Jul 2022
Contributed by Lukas
Dr. Maria Elisa Mancuso chaired a symposium at the recent ISTH 2022 congress. The main topic was to try to understand which are the clinical met needs...
Anticoagulant Advancements for VTE in Children - report from ISTH2022
29 Jul 2022
Contributed by Lukas
We asked Professor Heleen van Ommen about a symposium presented on the ISTH 2022 congress in London, which was about pediatric thrombosis. Video: http...
Clinical Challenges in Patients with Venous Thromboembolism - report from ISTH2022
28 Jul 2022
Contributed by Lukas
Professor Walter Ageno shared us his thoughts on a symposium he took part on the recent ISTH 2022 congress, which addressed very practical issues in t...
Good practice statements for antithrombotic therapy in the management of COVID-19 - report from ISTH2022
28 Jul 2022
Contributed by Lukas
Professor Alex Spyropoulos shared with us the guidance statement of the Scientific Standardization Committee of the ISTH about the good practice state...
ISTH Proposal to Standardize Functional Assays in the Diagnosis of Heparin‐induced Thrombocytopenia - report from ISTH2022
27 Jul 2022
Contributed by Lukas
Professor Ishac Nazy held an interesting symposium durint the recent ISTH 2022 congress. He shared us his thought about ISTH proposal to standardize f...
Navigating the Joint Health Journey for Patients With Hemophilia - report from ISTH2022
27 Jul 2022
Contributed by Lukas
Professor Margareth C. Ozelo shared us his thought about a symposium held at the recent ISTH 2022, which topic was about general issues related to joi...
Strategies for Assessing and Managing DOAC-Related Bleeding - report from ISTH2022
26 Jul 2022
Contributed by Lukas
Professor Deborah Siegal chaired an interesting symposium during the ISTH 2022 congress in London, the topic was strategies for assessing and managing...
Approaches to Standardisation and Monitoring for Haemophilia Gene Therapy: Consistency, Considerations and Challenges - report from ISTH2022
26 Jul 2022
Contributed by Lukas
Professor Johnny Mahlangu shared with us a symposium that they organized during the ISTH 2022 congress. They examined approaches to standardisation an...
Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism - report from ISTH2022
25 Jul 2022
Contributed by Lukas
We asked Dr. Emma Leitinger about their work which was presented as a poster at the recent ISTH 2022 congress. Video: https://congressreport.eu/scient...
Roles of FVIII in Endothelial Cell Biology: More than a Coagulation Factor? - report from ISTH2022
25 Jul 2022
Contributed by Lukas
We asked Professor Antonia Follenzi about their research data on the role of Factor VIII, what she presented on the recent ISTH 2022 congress in Londo...
Diagnosis and management of primary aldosteronism - report from ESH2022
25 Jul 2022
Contributed by Lukas
Professor Paolo Mulatero co-chaired a Meet the Expert session about the novelties diagnosis and management of primary aldosteronism at the recent ESH ...
Adherence to antihypertensive treatment in patients with CKD: a barrier to optimal renoprotection - report from ISTH2022
22 Jul 2022
Contributed by Lukas
We asked Professor Michel Burnier about the adherence to antihypertensive treatment in patients with CKD, what he presented at the ESH Working Group o...
Brain cancers and the risk of intracranial hemorrhage with DOACs versus Low Molecular Weight Heparin - report from ISTH2022
22 Jul 2022
Contributed by Lukas
We asked Professor Philip Haddad about anticoagulation treatment of patients with brain tumor. Professor Haddad presented a meta-analysis of the use o...
Special forms of hypertension, optomized prevention and hypertension epidemiology - report from ESH2022
22 Jul 2022
Contributed by Lukas
Professor Gianfranco Parati took part in many interesting sessions during the recent European Society of Hypertension. We asked to share his insight o...
“Ten months of needles, we’d better get it right!” - The Highlow Study - report from ISTH2022
21 Jul 2022
Contributed by Lukas
Professor Saskia Middeldorp presented the result of the Highlow Study at the recent ISTH 2022 congress in London, which investigated the different dos...
ISTH Guidelines for Anticoagulation in COVID-19 - report from ISTH2022
21 Jul 2022
Contributed by Lukas
We asked Professor Sam Schulman about the ISTH Guidelines on antithrombotic treatment in COVID-19. Video: https://congressreport.eu/scientific-content...